Security key
68403P203
ORAMED PHARMACEUTICALS INC. - Common Stock (ORMP)
CUSIP: 68403P203
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 5,933,749
- Total 13F value
- $15,249,519
- Share change
- +672,097
- SEC-reported price per share
- $2.57
- Number of holders
- 58
- Value change
- +$1,726,907
- Number of buys
- 22
- Number of sells
- 16
- Shares outstanding
- 40,467,431
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
58
Top holders
10
ORMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
ORAMED PHARMACEUTICALS INC. SEC filings
ORAMED PHARMACEUTICALS INC. company facts
ORAMED PHARMACEUTICALS INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 68403P203
Recent filing periods:
Ownership snapshot
Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Murchinson Ltd.
Disclosed value leader
Murchinson Ltd.
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 3.4%
Showing 1-6 of 15 holder rows.
Quick read
Murchinson Ltd. leads the comparable SEC ownership view at 3.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Murchinson Ltd.'s linked filing trail.
Comparable ownership
Top 5
Murchinson Ltd.
3.4%
BML Capital Management, LLC
2.1%
BOOTHBAY FUND MANAGEMENT, LLC
1.7%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.85%
Rathbones Group PLC
0.72%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Murchinson Ltd. |
13F
Company
|
3.4%
|
$4,028,125
1,379,495 shares
|
— | 31 Mar 2024 |
| BML Capital Management, LLC |
13F
Company
|
2.1%
|
$2,465,928
844,496 shares
|
— | 31 Mar 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
1.7%
|
$2,014,067
689,749 shares
|
— | 31 Mar 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.85%
|
$1,005,759
344,438 shares
|
— | 31 Mar 2024 |
| Rathbones Group PLC |
13F
Company
|
0.72%
|
$846,225
289,803 shares
|
— | 31 Mar 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.71%
|
$838,192
287,052 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
58
Shares
5,933,749
Rows available
58
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
51
Q2 2024 holders
58
Holder diff
7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend